Illinois Municipal Retirement Fund reduced its holdings in Humana Inc. (NYSE:HUM – Free Report) by 5.4% in the second quarter, HoldingsChannel reports. The firm owned 39,577 shares of the insurance provider’s stock after selling 2,281 shares during the period. Illinois Municipal Retirement Fund’s holdings in Humana were worth $14,788,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. Private Wealth Management Group LLC bought a new stake in Humana in the fourth quarter worth approximately $32,000. CarsonAllaria Wealth Management Ltd. increased its holdings in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Hantz Financial Services Inc. bought a new stake in Humana in the second quarter worth approximately $35,000. Family Firm Inc. bought a new stake in Humana in the second quarter worth approximately $37,000. Finally, Carolinas Wealth Consulting LLC increased its holdings in shares of Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after acquiring an additional 74 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
HUM has been the subject of several recent research reports. Robert W. Baird initiated coverage on Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price objective for the company. Oppenheimer boosted their price objective on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Baird R W upgraded Humana to a “hold” rating in a report on Thursday, May 30th. Bank of America boosted their price objective on Humana from $342.00 to $376.00 and gave the company a “neutral” rating in a report on Monday, May 20th. Finally, Truist Financial boosted their price objective on Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. Thirteen equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $398.70.
Humana Stock Performance
HUM stock traded down $7.28 during midday trading on Friday, hitting $357.86. The company’s stock had a trading volume of 1,080,228 shares, compared to its average volume of 1,625,801. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock’s 50-day moving average price is $367.68 and its 200 day moving average price is $347.41. The stock has a market cap of $43.12 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 3.16 and a beta of 0.51.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the prior year, the firm earned $8.94 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. On average, equities analysts forecast that Humana Inc. will post 16.14 EPS for the current year.
Humana Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.99%. Humana’s dividend payout ratio is presently 22.04%.
Humana Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
See Also
- Five stocks we like better than Humana
- How to Calculate Stock Profit
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- Ride Out The Recession With These Dividend KingsĀ
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- 3 Monster Growth Stocks to Buy Now
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.